Comparative Efficacy and Immunogenicity of Infliximab and Adalimumab in Crohn's Disease: A Prospective Cohort Study.

Medicina (Kaunas) · 2025 · PMC12734427 · PMID 41470167

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

As shown in Table 3 , the evaluation of the AUC for drug levels, anti-drug antibodies, and TNFα did not reach statistical significance for either IFX or ADA, suggesting that these markers are not effective in distinguishing between active disease and remission.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.